Essential Partners’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.62K Sell
63
-195
-76% -$4.52K ﹤0.01% 2058
2026
Q1
$5.31K Buy
258
+74
+40% +$1.67K ﹤0.01% 1541
2025
Q4
$4.36K Hold
184
– – ﹤0.01% 1482
2025
Q3
$4.58K Buy
184
+8
+5% +$172 ﹤0.01% 1457
2025
Q2
$4.05K Buy
+176
New +$4.08K ﹤0.01% 1115

Other funds holding PRVA

Essential Partners's PRVA Position: Q2 2026 in Review

Essential Partners reduced its Privia Health (PRVA) stake by 76% in Q2 2026, selling an estimated $4.52K and leaving 63 shares worth $1.62K. The position accounts for ﹤0.01% of the portfolio, ranked #2058.

Essential Partners first reported a position in PRVA in Q2 2025 and has held it in 5 quarters since. The position peaked at $5.31K in Q1 2026. 302 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • Essential Partners held 63 shares of Privia Health worth $1.62K as of Q2 2026.
  • Essential Partners sold 195 Privia Health shares in Q2 2026, an estimated $4.52K.
  • Privia Health made up ﹤0.01% of Essential Partners's portfolio in Q2 2026, its #2058 holding.
  • Essential Partners first reported a position in Privia Health in Q2 2025 and has held it in 5 quarters since.
  • Essential Partners's Privia Health position peaked at $5.31K in Q1 2026.
  • 302 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.